scorecard

You Searched For "cipla acquisition" and got 19 results


Sort By:


Business Insider Latest Story Image
3 mins read

Market says Torrent better fit for Cipla as Dr Reddy’s and Blackstone join fray

The promoters of one of India’s oldest pharma companies Cipla want to exit the business, and it’s n…

Business Insider Latest Story Image
2 mins read

ITC to acquire 16% stake in Mother Sparsh that focuses on baby care segment

"The said acquisition will, inter alia, enable access to the fast-growing direct to consumer (D2…

PTI   


Business Insider Latest Story Image
1 min read

Cipla to acquire 21.85 pc stake in GoApptiv

GoApptiv offers digital solutions for integrated brand sales management, digital marketing and cha…

PTI   


Business Insider Latest Story Image
2 mins read

Top stocks to watch — RIL, Airtel, Vodafone-Idea, Infosys, Wipro, Shalby, Cipla, and others

Amidst mixed cues from the global markets, the Indian stock market is likely to open with a negativ…

Business Insider Latest Story Image
3 mins read

Top stock movers — RIL, Granules, TCS, Cipla, Advanced Enzyme Tech, Tata Consumer, and more

Indian stock market index Sensex gained over 400 points on Friday, led by positive cues from global…

Business Insider Latest Story Image
1 min read

Cipla acquires 4 nutrition brands from Wanbury

This includes supplements such as multivitamins, multimineral and antioxidants for adolescent girl…

PTI   


Business Insider Latest Story Image
8 mins read

Exclusive: Gozoop Group acquires Stratton Communications; acquired agency will be rebranded as Sm(all) and will focus on challenger brands

Acquired agency Sm(all) aims to move beyond advertising and focus on creating a cult following for …

Business Insider Latest Story Image
1 min read

Cipla Strikes $14 Million Deal With Its Sri Lankan Drug Distributor

​The Indian company has operated in Sri Lanka for more than 15 years.

Business Insider Latest Story Image
2 mins read

Sensex, Nifty50 end slightly higher led by gains in RIL, Infosys, ITC

Sensex ended 126.76 points or 0.22% higher at 57,653 while Nifty50 gained 40.65 points or 0.24% at …

Business Insider Latest Story Image
4 mins read

Sensex, Nifty50 edge up in morning trade: Metal, pharma sector stocks rise

India’s benchmark indices Sensex and Nifty50 are likely to see a gap-up opening on Wednesday amid p…

Business Insider Latest Story Image
4 mins read

Sensex, Nifty50 open higher amid positive global cues; metal, IT, PSU banks top gainers

All sectoral indices were in the green, metal, IT and PSU Banks were the top gainers. Adani Enterpr…

Business Insider Latest Story Image
5 mins read

Indian markets end higher after a choppy session – PSU banks, IT, FMCG gain

Indian markets ended higher after a choppy session on Friday led by gains in public-sector banks, i…

Business Insider Latest Story Image
7 mins read

If you are looking to add sparkle to your portfolio this Diwali, here are ten stocks for Samvat 2079

Samvat 2078 has been a year of some highs and many lows. Despite all odds, Indian equities have far…

Business Insider Latest Story Image
3 mins read

Nykaa is now bigger than Coal India, Britannia, IRCTC and almost double of Hero MotoCorp

Fashion and beauty ecommerce platform Nykaa made a strong debut on the stock exchanges on November …

Business Insider Latest Story Image
1 min read

ONGC set to merge refining subsidiary MRPL with HPCL by June 2021

Sources said that the process of merging ONGC's two oil refining subsidiaries, HPCL and MRPL, wi…

Business Insider Latest Story Image
1 min read

Former Myntra CEO Ananth Narayanan joins online pharmacy Medlife

There were rumours that Narayanan left his position as Myntra Jabong’s CEO because of his misali…

Business Insider Latest Story Image
2 mins read

Cadila's new drug for rheumatoid arthritis gets permission for clinical trials in India

Indian drug maker Cadila Healthcare— which also owns brands like Complan, Glucon D, and Nycil aft…

Business Insider Latest Story Image
2 mins read

US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months

As a result of an agreement with the drug maker announced earlier this week, the US Department …

Business Insider Latest Story Image
5 mins read

These Are The 7 Nifty Stars To Look Out For In 2014

Heavyweights are likely to do better in 2014, not just because of their vast potential but also due…

Economic Times